Rates of hospitalization associated with the use of aldosterone receptor antagonists in patients with pulmonary arterial hypertension

We show that spironolactone use was associated with an increased rate of all-cause hospitalizations, but no difference in hospitalizations for heart failure or pulmonary arterial hypertension, in patients with World Health Organization Group 1 pulmonary arterial hypertension. A possible reason for this finding is confounding from retrospective study design.

Published in:

Pulmonary Circulation Vol 9: No 3 cover image

September 2019

Pulmonary Circulation Vol 9: No 3

View this journal

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI